,
Erik Vollebregt
It’s time for a celebration! Why? Did the ENVI committee magically produce a proposal that makes a lot of sense, and ahead of time? Unfortunately not – we still have to wait…
,
Erik Vollebregt
I have just written annotations to the Abbvie and Intermune cases under EU pharmaceutical law for the next issue of the Dutch legal journal Jurisprudentie Geneesmiddelenrecht (in Dutch, sorry) but of course that…
,
Erik Vollebregt
The scope of the concept of medical device is in constant flux. The EU amended the definition slightly in 2007 to accomodate for standalone software as medical device, the GHTF changed its…
,
Karin Verzijden
Food information services by Google Recently, Google added nutritional information into its search functionality relating to more than 1,000 food items ranking from fruits to vegetables and from meats to complete meals….
,
Erik Vollebregt
Further to my recent post about e-labeling and my appeal to take more account of the specific mHealth market needs I had a discussion with another devices expert who suggested that the majority of medical…
,
Erik Vollebregt
The e-labeling regulation has entered into full force a couple of months ago (1 March 2013), and I thought it would be a nice idea to share some of my experience with the new…
,
Karin Verzijden
On 5 and 6 September 2013, the Autumn College on EU Food Law will take place in Brussels. This event offers a unique opportunity to receive a profound insight and practical understanding…
,
Karin Verzijden
Karin is a Dutch attorney-at-law who co-founded the boutique life sciences law firm Axon Lawyers in Amsterdam. Her interest in food legislation stems from a combination of professional involvement and a personal…
,
Karin Verzijden
Sofie is a lawyer working @ the boutique life sciences law firm Axon Lawyers in Amsterdam. Sofie has gained broad experience in advice and litigation in the field of administrative law. @…